Contributor Page
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
 
Email  |  Website  |  Articles
Contact Details
Tel: +1 617 5426000
Fax: +1 617 5422241
One Financial Center
Boston
MA 02111
United States
Awards
By Thomas Burton III
Given this backdrop, it seems like a good time to review some of the most important trends and policies concerning clean energy that we covered in 2016.
By Susan Cohen
On January 17, 2017, USCIS published a final rule in the Federal Register amending the immigration regulations to expand the use of the government's "parole" authority...
By Michael Renaud, William Meunier, Peter Cuomo, Inna Dahlin
But ImmunoGen argued that Phigenix lacked standing, and the Federal Circuit ultimately agreed, dismissing Phigenix's appeal.
By Christina Sperry, Monique Winters Macek
Important factors identified by the UPC in meeting these dates are the necessary ratifications of the UPCA and accession to the Protocol on Provisional Application.
By Joanne Hawana, Bethany J. Hills
This post will outline some of our thoughts related to what could face FDA and its various stakeholders as we go forward into the great unknown.
By Michael Arnold, Brie Kluytenaar
On Friday, the Supreme Court agreed to decide the issues of whether employers may include class/collective action waivers in their arbitration agreements.
By Joanne Hawana
The article examines certain defenses in consumer fraud class actions over product labeling – specifically, defenses based on faulty damages models...
By Joanne Dynak, Michael Katz, Cynthia Larose
The FTC has filed a lawsuit against device manufacturer D-link for allegedly deceiving the marketplace about the security of its products and, in turn, unfairly placing customer privacy at risk.
By Inna Dahlin, Brad Scheller
The New Year brings excitement and anticipation of changes for the best. Some of the pending patent cases provide us with ample opportunity to expect something new...
By Ellyn Sternfield, Rodney Whitlock
Back in early October, we were all transfixed by the announced Mylan settlement with the U.S. Department of Justice (DOJ) over Mylan's alleged underpayments of Medicaid Drug Rebates for the EpiPen.
By Susan Neuberger Weller
Although most people will recognize the ubiquitous PIZZA! PIZZA! slogan mark owned by the pizza chain Little Caesar's, the company's collection of repeated term marks does not rise to...
By Benjamin Zegarelli, Eli Greenspan, Joanne Hawana
Over the past year or so, House Republicans have decried the negative economic effects of the Final Deeming Rule and other tobacco regulations promulgated by FDA.
By Adam Samansky, Joseph Rutkowski
On Monday, January 9, 2017, the U.S. Supreme Court denied, without comment, Mylan Pharmaceuticals' petition for certiorari to reverse an opinion by the Court of Appeals for the Federal Circuit, . . .
By Susan Neuberger Weller
As we reported to you last September, the U.S. Supreme Court agreed to hear the case involving the constitutionality of the provisions of the Lanham Act...
By Eli Greenspan, Benjamin Zegarelli
The House of Representatives recently passed the Midnight Rules Relief Act of 2017 largely along party lines.
Contributor's Topics
More...